In a study presented at the European Society for Medical Oncology Congress, researchers found that intravenous patient-controlled hydromorphone provided better pain control and higher patient satisfaction compared to conventional oral morphine in managing severe cancer pain. The study involved 1364 patients and showed that intravenous administration of hydromorphone, with or without continuous infusion, was superior to oral morphine. Patients receiving intravenous hydromorphone used less morphine and experienced fewer side effects. The findings suggest that intravenous administration may be more effective for severe cancer pain relief than oral administration. Researchers believe this study could lead to changes in pain relief administration practices in the future.
Source link
Patient-Controlled Analgesia Offers Superior Pain Management
